Drug-coated balloon in the treatment of coronary bifurcation lesions: A hope or hype?
Dash D, Mody R, Ahmed N, Malan SR, Mody B.
Indian Heart J. 2022 Nov-Dec;74(6):450-457. doi: 10.1016/j.ihj.2022.10.193. Epub 2022 Nov 5.
Riku S, Suzuki S, Yokoi T, Sakaguchi T, Yamamoto T, Jinno Y, Tanaka A, Ishii H, Inden Y, Murohara T.
Nagoya J Med Sci. 2022 May;84(2):352-365. doi: 10.18999/nagjms.84.2.352.
Treatment with a dedicated bifurcation sirolimus-eluting cobalt-chromium stent for distal left main coronary artery disease: rationale and design of the POLBOS LM study.
Asano T, Kogame N, Onuma Y, Modolo R, Chichareon P, Lefèvre T, Legutko J, Digne F, Morel MA, Serruys PW, Gil RJ.
EuroIntervention. 2020 Oct 23;16(8):654-662. doi: 10.4244/EIJ-D-19-00361.
Comparison of single- versus two-stent techniques in treatment of unprotected left main coronary bifurcation disease.
Kim WJ, Kim YH, Park DW, Yun SC, Lee JY, Kang SJ, Lee SW, Lee CW, Park SW, Park SJ.
Catheter Cardiovasc Interv. 2011 May 1;77(6):775-82. doi: 10.1002/ccd.22915. Epub 2011 Jan 4.
Application of Drug-Coated Balloons in Complex High Risk and Indicated Percutaneous Coronary Interventions.
Somsen YBO, Rissanen TT, Hoek R, Ris TH, Stuijfzand WJ, Nap A, Kleijn SA, Henriques JP, de Winter RW, Knaapen P.
Catheter Cardiovasc Interv. 2025 Feb;105(2):494-516. doi: 10.1002/ccd.31316. Epub 2024 Dec 11.
Clinical outcomes of a dedicated bifurcation stent system.
Sivalingam J, Mazhar MW, Chaddad RA, Fouladvand F, Cortese B.
Cardiovasc Revasc Med. 2024 Feb;59:21-26. doi: 10.1016/j.carrev.2023.08.015. Epub 2023 Aug 31.
Treatment of coronary bifurcation lesions with bioresorbable vascular scaffolds.
Capranzano P, Gargiulo G, Capodanno D, Longo G, Tamburino C, Ohno Y, Attizzani GF, La Manna A, Di Salvo M, Francaviglia B, Grasso C, Sgroi C, Tamburino C.
Minerva Cardioangiol. 2014 Jun;62(3):229-34.
Unprotected left main coronary artery bifurcation stenosis: impact of plaque debulking prior to single sirolimus-eluting stent implantation.
Tanaka N, Terashima M, Kinoshita Y, Kimura M, Nasu K, Ehara M, Tsuchikane E, Matsubara T, Asakura Y, Katoh O, Suzuki T.
J Invasive Cardiol. 2008 Oct;20(10):505-10.
Mid-term clinical outcomes of ABSORB bioresorbable vascular scaffold versus everolimus-eluting stent for coronary bifurcation lesions.
Naganuma T, Kawamoto H, Panoulas VF, Latib A, Tanaka A, Mitomo S, Ruparelia N, Jabbour RJ, Chieffo A, Carlino M, Montorfano M, Colombo A.
Int J Cardiol. 2017 Nov 1;246:26-31. doi: 10.1016/j.ijcard.2017.03.123.
First-in-man study of dedicated bifurcation cobalt-chromium sirolimus-eluting stent BiOSS LIM C - three-month results.
Gil RJ, Bil J, Kern A, Pawłowski T.
Kardiol Pol. 2018;76(2):464-470. doi: 10.5603/KP.a2017.0226. Epub 2017 Dec 1.
